15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was to evaluate the effects of perioperative systemic chemotherapy (CT) on short-term surgical and long-term oncologic results in diffuse malignant peritoneal mesothelioma (DMPM) patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

          Related collections

          Author and article information

          Journal
          Ann. Surg. Oncol.
          Annals of surgical oncology
          1534-4681
          1068-9265
          Apr 2013
          : 20
          : 4
          Affiliations
          [1 ] Peritoneal Surface Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. marcello.deraco@istitutotumori.mi.it
          Article
          10.1245/s10434-012-2845-x
          23456386
          7e78dfa2-678b-4a74-a7d7-9a3090e3fe7b
          History

          Comments

          Comment on this article